RISKS AND COSTS OF END-STAGE RENAL DISEASE AFTER HEART TRANSPLANTATION1,2

Abstract

In a large, national sample of patients undergoing heart transplantation, ESRD is not rare, even for patients undergoing transplant after the development of new practices intended to reduce its occurrence. ESRD remains an important component of the costs of heart transplantation.